ClinicalTrials.gg
Active, not recruitingNCT04187612Updated Apr 6, 2026

Association of Body Fluid Distribution With Obstructive Sleep Apnea in Pregnant Women With Body Mass Index ≥ 40 kg/m2

An observational study in Apnea, Obstructive Sleep and Obesity, sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Active, not recruiting at 1 site in Canada. Open to female participants aged 16 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-06.

Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
52
Ages
16 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 133 studies in Sleep Apnea, Obstructive with a site in Canada — 22 open to participants now, 31 under way, 4 of them phase 3. Sleep Apnea, Obstructive · Canada.

Planned enrollment
21st of 31
52 · median 100
Started
2019
with 9 others
Observational
31 of 133
8 open now
Primary completion
2026-12
later than 11 of 30 live
Registered
92nd of 133
by date

Among the 133 studies in Sleep Apnea, Obstructive with a site in Canada, this one is the 21st largest by planned enrollment of the 31 observational ones that give a count, is one of 10 that started in 2019, is one of 31 observational ones, reaches primary completion later than 11 of the 30 other live ones, and was the 92nd registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

22 of the 133 studies in Sleep Apnea, Obstructive with a site in Canada are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 16 Years to 50 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 133 studies in Sleep Apnea, Obstructive with a site in Canada, or all of them as a file.
02

Study summary

Obstructive Sleep apnea (OSA) is a common and underdiagnosed condition in obese pregnant women with serious and life-threatening complications to the mother and baby. The investiators propose that a non-invasive method may be used to detect patients at risk of OSA, giving these women access to the necessary treatment to treat this condition. The method is a estimation of body water, which has been shown to be linked to OSA in the non-pregnant population. Body water is estimated by applying surface electrodes to a participant who is lying down by measuring bioimpedance through body tissues by applying a tiny current between the electrodes. The electrical stimulation is not felt by the participant and has no negative effects on mother or baby.

Read the detailed description

It is already established that the increasingly prevalent condition of obesity is linked to OSA in pregnancy. Obesity is increasingly prevalent This study will evaluate a novel method of screening for OSA in the obese pregnant population, thereby treating this condition reducing the ill effects to mother and fetus.

This will be a prospective observational cohort study. Eligible participants will be approached for consent during their third-trimester antenatal all-day clinic visit. Body water will be measured by connecting electrodes to participants hands, feet and neck whilst lying supine for approximately 15 minutes.

Data on patient demographics, BMI, medical conditions, water body composition and indicators of OSA (breathing pattern and oxygen levels during sleep) will be collected, as well as data from patients' sleep tests as ordered by their physician.

03

Conditions studied

  • Apnea, Obstructive Sleep
  • Obesity

Keywords

  • pregnancy
04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Eligible participants will be approached for consent at our high risk maternal and infant program clinic on the day of their regularly scheduled appointment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants who give written
  • Pregnant women in the third trimester of pregnancy
  • Grade III obesity
  • Patients who have prior diagnosis of OSA within the last one year, and non-compliant to treatment such as continuous positive airway pressure (CPAP), or dental appliance
  • Patients suspected to have OSA based on screening questionnaire (see page 2, OSA-Diagnostic tools for further details)

Exclusion criteria

Exclusion Criteria:

  • Fluid overload states including renal disease, liver disease and congestive heart failure
  • Prior history of vascular surgery in the lower limbs such as varicose vein surgery, vascular by-pass surgery or evidence of venous efficiency.
  • Patients with metal implants in lower limbs or spine, due to possible interference with the leg impedance signals. 58
  • Participants with diagnosed OSA treated with Continuous Positive Airway Pressure (CPAP).
  • Patients requiring urgent sleep physician referral (within four weeks) due to serious medical conditions or safety critical-occupations according to the 2011 Canadian Thoracic Society (CTS) guideline 59 e.g. unstable ischemic heart disease, recent cerebrovascular disease.
  • Implantable cardiac devices
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
52 participants (estimated)
Patient registry
No

Groups and cohorts

  • Total body water measurement

    Total body water will be measured using Bioelectrical Impedance Analysis (BIA).

    Device: Bioelectrical Impedance Analysis (BIA)

Interventions

  • DeviceBioelectrical Impedance Analysis (BIA)

    BIA will be used to determine total body water

06

What researchers measure

Primary outcomes

  1. Presence of sleep apnea

    The diagnosis of sleep apnea will be made using apnea hypopnea index (AHI). A diagnosis of OSA is present if a person has an AHI ≥5/hour.

    Time frame: 12 hours

Secondary outcomes

  1. Total body water measurement

    Total body water will be measured using Bioelectrical Impedance Analysis (BIA)

    Time frame: Following consent, this measurement will be done, and will take approximately 30 minutes

  2. Mallampati score

    The patient is asked to open their mouth wide and stick out their tongue. Upon observation, the view is classified/scored as Class 1-4. Class one would be least likely to have airway problems and 4 most likely.

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  3. Thyromental distance (cm)

    The distance between the thyroid notch and the tip of the jaw with the head extended is evaluated.

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  4. Subluxation of mandible beyond maxilla

    The patient is asked to extend their mandible beyond the top lip if possible. Scoring is yes or no.

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  5. Neck extension

    The patient is asked to extend their neck, looking upwards and back, as far as comfortably possible. Scoring is yes if movement is possible, no if extension is not possible.

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  6. Height (cm)

    Height measured in cm to calculate Body Mass index (BMI)

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  7. Weight (kg)

    Weight measured in kg to calculate Body Mass index (BMI)

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  8. Neck size

    Circumference around the neck, measured in centimeters.

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  9. Questionnaire related to snoring

    Patients will be asked if they snore, if others can hear their snoring and if they are bothered by it. Yes or no answers.

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

  10. Questionnaire related to sleep

    Patients will be asked if they wake frequently during sleep, if they wake with a choking sensation, and whether they doze off or fall asleep while sitting/talking. Yes or no answers.

    Time frame: Done during initial exam following consent, this exam will take 1-2 minutes

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2019 (actual). Primary completion is estimated for Dec 2026, 84 months after the start.

Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's planned 84 months is above that.

Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2019
First posted
Dec 5, 2019
StartActual
Dec 2, 2019
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Apr 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04187612
Responsible party
Sponsor
First posted
Dec 5, 2019
Start date
Dec 2, 2019
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 6, 2026

Study contacts

Mrinalini Balki, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion